{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:04:25Z","timestamp":1783951465630,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jchromb.2020.122388","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:25:19Z","timestamp":1602505519000},"page":"122388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues"],"prefix":"10.1016","volume":"1166","author":[{"given":"Pedro Henrique Reis","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando da Silva","family":"Cunha J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson Ant\u00f4nio","family":"Pianetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122388_b0005","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2020.122388_b0010","first-page":"1","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jchromb.2020.122388_b0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2020.122388_b0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcjo.2012.02.003","article-title":"Epidemiology of glaucoma: What\u2019s new?","volume":"47","author":"Cook","year":"2012","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0030","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jchromb.2020.122388_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000458482","article-title":"Achievements and Limits of Current Medical Therapy of Glaucoma","volume":"59","author":"Kalouda","year":"2017","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"Conlon","year":"2017","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/mja2.50020","article-title":"Current management of glaucoma","volume":"210","author":"Lusthaus","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jchromb.2020.122388_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of Glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0055","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society, Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options, Br. J. Ophthalmol. 101 (2017) 130-195. doi: 10.1136\/bjophthalmol-2016-EGSguideline.003.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"key":"10.1016\/j.jchromb.2020.122388_b0060","unstructured":"P. Susan Standring DSc, Gray\u2019s anatomy 41st edition: The anatomical basis of clinical practice, 2016."},{"key":"10.1016\/j.jchromb.2020.122388_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/164_2016_32","article-title":"Ocular pharmacokinetics","volume":"242","author":"Durairaj","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122388_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jchromb.2020.122388_b0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2020.122388_b0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jchromb.2020.122388_b0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/164_2016_84","article-title":"Ocular drug delivery","volume":"242","author":"Yavuz","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122388_b0090","doi-asserted-by":"crossref","unstructured":"D. Yadav, L.T. Varma, K. Yadav, Drug Delivery to Posterior Segment of the Eye: Conventional Delivery Strategies, Their Barriers, and Restrictions, in: Drug Deliv. Retin. Posterior Segm. Dis., Springer, New York 2018, pp. 51\u201367. doi:10.1007\/978-3-319-95807-1_3.","DOI":"10.1007\/978-3-319-95807-1_3"},{"key":"10.1016\/j.jchromb.2020.122388_b0095","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.4155\/bio-2017-0175","article-title":"Ocular bioanalysis: challenges and advancements in recent years for these rare matrices","volume":"9","author":"Heinig","year":"2017","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2020.122388_b0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1570-0232(02)00023-5","article-title":"Determination of betaxolol in human aqueous humour by high-performance liquid chromatography with fluorescence detection","volume":"772","author":"Dulger","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/108076802317233225","article-title":"Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit","volume":"18","author":"Tiss\u00ed","year":"2002","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200204000-00009","article-title":"Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing","volume":"11","author":"Tan","year":"2002","journal-title":"J. Glaucoma."},{"key":"10.1016\/j.jchromb.2020.122388_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/bmc.529","article-title":"Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels","volume":"20","author":"Wei","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2020.122388_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/jop.2006.22.333","article-title":"Improvement of the ocular bioavailability of carteolol by ion pair","volume":"22","author":"Higashiyama","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1167\/iovs.05-0945","article-title":"Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration","volume":"47","author":"Holl\u00f3","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2007.05.009","article-title":"Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery","volume":"120","author":"Cao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2020.122388_b0135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jchromb.2010.01.041","article-title":"Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography\/atmospheric pressure chemical ionization mass spectrometry","volume":"878","author":"Zammataro","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jat\/34.6.312","article-title":"Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry","volume":"34","author":"Pelander","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122388_b0145","doi-asserted-by":"crossref","unstructured":"L. Padrini, B. Isacchi, A.R. it. Bilia, A. Pini, C. Lanzi, E. Masini, M.L. uis. Della Bona, A.M. ari. Calvani, R. Ceccantini, G. la Marca, L. Filippi, Pharmacokinetics and local safety profile of propranolol eye drops in rabbits, Pediatr. Res. 76 (2014) 378\u2013385. doi:10.1038\/pr.2014.108.","DOI":"10.1038\/pr.2014.108"},{"key":"10.1016\/j.jchromb.2020.122388_b0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.talanta.2014.06.074","article-title":"Simultaneous determination of dorzolomide and timolol in aqueous humor: a novel salting out liquid-liquid microextraction combined with HPLC","volume":"130","author":"Mohamed","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122388_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jop.2014.0015","article-title":"The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes","volume":"31","author":"Fukuda","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0160","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00216-015-8574-9","article-title":"A simple method for the subnanomolar quantitation of seven ophthalmic drugs in the rabbit eye","volume":"407","author":"Latreille","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2020.122388_b0165","first-page":"109","article-title":"Simultaneous determination of timolol maleate in combination with some other anti-glaucoma drugs in rabbit aqueous humor by high performance liquid chromatography-tandem mass spectroscopy, J. Chromatogr. B Anal. Technol. Biomed","volume":"1022","author":"Hassib","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/jop.2016.0028","article-title":"Ocular penetration and pharmacokinetics of ripasudil following topical administration to rabbits","volume":"32","author":"Isobe","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121908","article-title":"Development and validation of a bio-analytical method for simultaneous quantification of nebivolol and labetalol in aqueous humor and plasma using LC-MS\/MS and its application to ocular pharmacokinetic studies","volume":"1136","author":"Rawat","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0180","first-page":"588","article-title":"Ocular intracameral pharmacokinetics for a cocktail of timolol, betaxolol, and atenolol in rabbits","volume":"17","author":"Fayyaz","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2020.122388_b0185","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.xphs.2019.04.012","article-title":"Pharmacokinetics and tissue distribution of pilocarpine after application to eyelid skin of rats","volume":"108","author":"See","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.30.4.421","article-title":"Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes","volume":"30","author":"Acheampong","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2020.122388_b0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/10807680260218498","article-title":"Formulation effects on ocular absorption of brimonidine in rabbit eyes","volume":"18","author":"Acheampong","year":"2002","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jchromb.2008.11.009","article-title":"A rapid and sensitive LC\/MS\/MS assay for the quantitation of brimonidine in ocular fluids and tissues","volume":"877","author":"Jiang","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0205","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1167\/iovs.13-13650","article-title":"Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown","volume":"20","author":"Shen","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0210","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/jop.2015.0003","article-title":"Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans","volume":"31","author":"Takamura","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40123-019-0180-z","article-title":"Effect of solution pH on distribution of ophthalmically administered brimonidine in posterior ocular tissues in pigmented rabbits","volume":"8","author":"Shinno","year":"2019","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2004.10.004","article-title":"Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration","volume":"102","author":"Sigurdsson","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2020.122388_b0225","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3109\/03639041003801893","article-title":"Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide","volume":"36","author":"Qian","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jchromb.2020.122388_b0230","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2010.07.005","article-title":"Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension","volume":"76","author":"Jansook","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jchromb.2020.122388_b0235","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.111.040055","article-title":"Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: Implications for effects on ocular blood flow","volume":"39","author":"Kadam","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2020.122388_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep44229","article-title":"Creation of nano eye-drops and effective drug delivery to the interior of the eye","volume":"7","author":"Ikuta","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2020.122388_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0191415","article-title":"Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures","volume":"13","author":"Afify","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2020.122388_b0250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjo.2006.110155","article-title":"Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract","volume":"91","author":"Cantor","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0255","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1124\/dmd.108.024885","article-title":"Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats","volume":"37","author":"Fukano","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2020.122388_b0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jop.2009.0098","article-title":"Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN\u00ae or TRAVATAN\u00ae","volume":"26","author":"Faulkner","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0265","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/OPTH.S15521","article-title":"Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits","volume":"4","author":"Ogundele","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0270","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jms.2004","article-title":"Development and validation of a liquid chromatography\/electrospray ionization tandem mass spectrometry method for the quantification of latanoprost free acid in rabbit aqueous humor and ciliary body","volume":"46","author":"Zammataro","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2020.122388_b0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jop.2011.0097","article-title":"Comparison of human ocular distribution of bimatoprost and latanoprost","volume":"28","author":"Ichhpujani","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0280","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2147\/OPTH.S179994","article-title":"Corrigendum: Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications (Clin Ophthalmol, (2017), 11, (1761\u20131767))","volume":"12","author":"Shen","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jchromb.2020.122388_b0285","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1167\/iovs.17-22429","article-title":"Pharmacokinetic and safety evaluation of a transscleral sustained unoprostone release device in monkey eyes","volume":"59","author":"Nagai","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejps.2016.05.016","article-title":"Topical delivery of a Rho-kinase inhibitor to the cornea via mucoadhesive film","volume":"91","author":"Chan","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0300","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.16-19585","article-title":"Biocompatibility and pharmacokinetic analysis of an intracameral polycaprolactone drug delivery implant for glaucoma","volume":"57","author":"Kim","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jchromb.2020.122388_b0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2013.216","article-title":"In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma","volume":"22","author":"Mart\u00ednez","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jchromb.2020.122388_b0310","first-page":"1","article-title":"Use of rabbit eyes in pharmacokinetic studies of intraocular drugs","volume":"2016","author":"Ahn","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jchromb.2020.122388_b0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jchromb.2020.122388_b0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10408347.2013.860874","article-title":"Newly introduced sample preparation techniques: towards miniaturization","volume":"44","author":"Costa","year":"2014","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jchromb.2020.122388_b0325","doi-asserted-by":"crossref","unstructured":"S. Honor\u00e9 Hansen, Steen And Pedersen-Bjergaard, Bioanalysis of Pharmaceuticals. Sample Preparation, Separation Techniques, and Mass Spectrometry, Hoboken, New Jersey, 2015, pp. 207\u2013259.","DOI":"10.1002\/9781118716830.ch9"},{"key":"10.1016\/j.jchromb.2020.122388_b0330","doi-asserted-by":"crossref","unstructured":"F. Pena-Pereira, Miniaturization in sample preparation, De Gruyter, Berlin 2014. doi:10.2478\/9783110410181.","DOI":"10.2478\/9783110410181"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220312642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220312642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:02:46Z","timestamp":1761606166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023220312642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":66,"alternative-id":["S1570023220312642"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122388","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122388"}}